Received Jul 2, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | 9L944 | — |
only received the liquid component and not the full reconstituted dose; only received the liquid component and not the full reconstituted dose; This non-serious case was reported by a other health professional via call center representative and described the occurrence of inappropriate preparation of medication in a 64-year-old male patient who received Herpes zoster (Shingrix) (batch number 9L944, expiry date 30-MAR-2027) for prophylaxis. On 18-JUN-2025, the patient received Shingrix. On 18-JUN-2025, an unknown time after receiving Shingrix, the patient experienced inappropriate preparation of medication (Verbatim: only received the liquid component and not the full reconstituted dose) and inappropriate dose of vaccine administered (Verbatim: only received the liquid component and not the full reconstituted dose). The outcome of the inappropriate preparation of medication and inappropriate dose of vaccine administered were not applicable. Additional Information: GSK Receipt Date: 23-JUN-2025 Reporter stated that they had a patient who only received the liquid component and not the full reconstituted dose. The patient received only adjuvant of Shingrix, which led to inappropriate preparation of medication and inappropriate dose of vaccine administered.